1. Ganymed Pharmaceuticals Ag (7 from 50 patents)

2. Biontech Ag (6 from 36 patents)

3. Johannes Gutenberg-Universität Mainz (2 from 44 patents)

4. Other (1 from 832,680 patents)

5. Ganymed Pharmaceuticals Gmbh (1 from 10 patents)

6. Astellas Pharma Gmbh (416 patents)

7. Biontech Se (66 patents)

8. Tron—translationale Onkologie An Der Universitátsmedizin Der Johannes Gutenberg—universitÄt Mainz Gemeinnützige Gmbh (23 patents)

1. 11473085 - Methods and compositions for diagnosis and treatment of cancer

2. 10724103 - Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy

3. 10302647 - Identification of surface-associated antigens for tumor diagnosis and therapy

4. 10036753 - Identification of surface-associated antigens for tumor diagnosis and therapy

5. 9910043 - Identification of tumor-associated cell surface antigens for diagnosis and therapy

6. 9809815 - Methods and compositions for diagnosis and treatment of cancer

7. 9733251 - Identification of tumour-associated cell surface antigens for diagnosis and therapy

8. 9533043 - Identification of surface-associated antigens for tumor diagnosis and therapy

9. 9267177 - Identification of tumor-associated cell surface antigens for diagnosis and therapy

10. 9255131 - Identification of surface-associated antigens for tumor diagnosis and therapy

11. 9194004 - Identification of surface-associated antigens for tumor diagnosis and therapy

12. 9139880 - Identification of tumor-associated cell surface antigens for diagnosis and therapy

13. 9090940 - Identification of surface-associated antigens for tumor diagnosis and therapy

14. 7875424 - Identification of tumour-associated cell surface antigens for diagnosis and therapy

15. 7785801 - Identification of surface-associated antigens for tumor diagnosis and therapy